<DOC>
	<DOCNO>NCT00422006</DOCNO>
	<brief_summary>Experimental result strongly suggest PCSK9 FXR could occur physiopathology human join dyslipidemia . But data literature validate potential role two gene lipidic glucidic metabolism control physiopathological situation . This protocol base hypothesis expression level PCSK 9 FXR modify patient suffer insulin resistance dyslipidemia .</brief_summary>
	<brief_title>Study Role PCSK9 FXR Physiopathology Joint Dyslipidemia Associated Human Immunoresistance</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>corporal mass index &gt; 40 kg/m² &gt; 35 kg/m² associate comorbidity resistant diet bariatric surgery plan lipidlowering drug 4 week surgery treatment metformin 4 week surgery treatment glitazones 8 week surgery age patient 18 65 year consent form sign patient social insurance age inferior 18 year woman pregnant coagulation trouble surgery contraindicate Chronic hepatitis B C active VIH infect chronic hepatic disease patient dyslipidemia lipidlowering drug secondary prevention cardiovascular pathology Type 2 diabetes insulinosensitivator treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>bariatric surgery plan</keyword>
</DOC>